All Latest Articles

Cataract & Refractive
Trifocal lens receives European CE mark

Alcon has received European CE mark for a trifocal IOL (AcrySof IQ PanOptix) designed for patients who are undergoing ...

Aflibercept fares well in treating DME
Who will benefit most from cataract ...
OCT could assist in laser tissue ...

Retina
Comparing anti-VEGFs for DME

In a 1-year comparison of intravitreous aflibercept, bevacizumab and ranibizumab therapy for centre-involved DME, ...

Lens opacity AREDS score predicts ...
NICE gives aflibercept provisional ...
Triamcinolone affects OCT ...

Glaucoma
Analyzing corneal asphericity, OCT ...

Corneal asphericity, OCT angiography, and balance control issues in glaucoma patients are analyzed in this industry ...

Low copay of generic PGA may improve ...
Lens extraction should be considered ...
AC is better than EDI for LC visibility

Latest Issue

OTE Articles

Aflibercept fares well in treating DMEIntravitreal aflibercept 2 mg every 8 weeks after 5 initial monthly doses (IVT-AFL 2q8) improved visual acuity outcomes in eyes with center-involved diabetic macular edema (DME) to a greater extent than intravitreal ranibizumab 0.5 mg as needed (IVR 0.5 mg PRN), though vascular endothelial growth factor (VEGF) inhibition with either IVT-AFL or IVR is efficacious and appears safe
Trifocal lens receives European CE markAlcon has received European CE mark for a trifocal IOL (AcrySof IQ PanOptix) designed for patients who are undergoing cataract surgery and want to address their near, intermediate, and distance vision needs with one lens.
OCT could assist in laser tissue bonding of corneal incisionsA laser tissue bonding apparatus integrated with an optical coherence tomography (OCT) probe is a plausible instrument that allows for temperature-controlled laser bonding of incisions in the cornea, according to Israeli researchers. The OCT probe can provide real-time feedback of structural change of the corneal tissue, and indicate the progress and end point of the bonding.

Advertisement

Who will benefit most from cataract surgery?A team of researchers from Denmark believes it has found a way for ophthalmologists to identify the patients who will most likely to benefit from age-related cataract surgery.
Gaming headset could offer a win for glaucoma patientsA gaming headset is helping researchers address balance issues in patients who have glaucoma.
PKal May Join VEGF as DME pathwayA protein called PKal (plasma kallikrein) and its associated molecules are key players in an inflammatory molecular pathway involved in diabetic macular edema, according to a study published in Diabetes.

Advertisement

Capsule opacification with 2 different IOLs: 3-year resultsThis follow-up study found anterior capsule opacification development and anterior capsule retraction to be more frequent 3 years after cataract surgery when an IOL with interrupted sharp optic edge at the optic–haptic junction is implanted, compared with an IOL with a continuous edge.
Glaucoma therapy: What if a PGA isn’t enough?In this article, Dr Tanna discusses treatment options for glaucoma patients who do not show satisfactory response to a PGA while taking into consideration the two key therapeutic choice factors: IOP-lowering efficacy and tolerability.
Navigated panretinal photocoagulation vs conventional pattern laser for PDRAn interventional trial recently compared standard and navigated pattern PRP techniques. In this article, Dr Kozak explains how continuous prepositioning and stabilisation of the aiming beam with navigated PRP, enables pattern application of the more effective longer pulse durations while reducing treatment times and broadens therapeutic options in proliferative diabetic retinopathy.
What to do when blebs start to failBleb failure can often be avoided with well-managed trabeculectomy and effective postoperative care.

Advertisement

Advertisement